Last Friday, U.K.-based Compass Pathways (NASDAQ: CMPS) became the first psychedelic medicine company to go public on a major U.S. exchange. The drugmaker's shares promptly rose by an eye-catching 70.5% during their first day of trading on the Nasdaq stock exchange. Compass' upward momentum, following this historic public debut, appears set to continue today, with the drugmaker's shares up by 10.8% in pre-market action Monday morning.
The Zacks Analyst Blog Highlights: JPM, PYPL, NVO, RHHBY and TM
Investors need to pay close attention to PayPal Holdings (PYPL) stock based on the movements in the options market lately.